SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-19-133019
Filing Date
2019-05-01
Accepted
2019-05-01 16:15:58
Documents
5
Period of Report
2019-05-01

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d740693d6k.htm 6-K 10454
2 EX-99.1 d740693dex991.htm EX-99.1 31461
3 EX-99.2 d740693dex992.htm EX-99.2 742634
4 GRAPHIC g740693g0501042214344.jpg GRAPHIC 4264
5 GRAPHIC g740693g0501043031334.jpg GRAPHIC 3289
  Complete submission text file 0001193125-19-133019.txt   796253
Mailing Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900 45 70 22 22 44
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36815 | Film No.: 19787747
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1